Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.

Hanna GJ, Kofman ER, Shazib MA, Woo SB, Reardon B, Treister NS, Haddad RI, Cutler CS, Antin JH, Van Allen EM, Uppaluri R, Soiffer RJ.

Oral Oncol. 2018 Jun;81:1-9. doi: 10.1016/j.oraloncology.2018.04.007. Epub 2018 Apr 10.

PMID:
29884406
2.

Frameshift events predict anti-PD-1/L1 response in head and neck cancer.

Hanna GJ, Lizotte P, Cavanaugh M, Kuo FC, Shivdasani P, Frieden A, Chau NG, Schoenfeld JD, Lorch JH, Uppaluri R, MacConaill LE, Haddad RI.

JCI Insight. 2018 Feb 22;3(4). pii: 98811. doi: 10.1172/jci.insight.98811. [Epub ahead of print]

3.

Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma.

Zolkind P, Przybylski D, Marjanovic N, Nguyen L, Lin T, Johanns T, Alexandrov A, Zhou L, Allen CT, Miceli AP, Schreiber RD, Artyomov M, Dunn GP, Uppaluri R.

Oncotarget. 2017 Dec 28;9(3):4109-4119. doi: 10.18632/oncotarget.23751. eCollection 2018 Jan 9.

4.

Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.

Redlich N, Robinson AM, Nickel KP, Stein AP, Wheeler DL, Adkins DR, Uppaluri R, Kimple RJ, Van Tine BA, Michel LS.

Cell Death Dis. 2018 Jan 5;9(1):5. doi: 10.1038/s41419-017-0029-0.

5.

CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.

Chung MK, Jung YH, Lee JK, Cho SY, Murillo-Sauca O, Uppaluri R, Shin JH, Sunwoo JB.

Clin Cancer Res. 2018 Feb 1;24(3):674-683. doi: 10.1158/1078-0432.CCR-17-0866. Epub 2017 Dec 5.

PMID:
29208672
6.

Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.

Hanna GJ, Adkins DR, Zolkind P, Uppaluri R.

Oral Oncol. 2017 Oct;73:65-69. doi: 10.1016/j.oraloncology.2017.08.008. Epub 2017 Aug 17. Review.

PMID:
28939078
7.

Checkpoint immunotherapy in head and neck cancers.

Zolkind P, Uppaluri R.

Cancer Metastasis Rev. 2017 Sep;36(3):475-489. doi: 10.1007/s10555-017-9694-9. Review.

PMID:
28836124
8.

Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.

Hanna GJ, Liu H, Jones RE, Bacay AF, Lizotte PH, Ivanova EV, Bittinger MA, Cavanaugh ME, Rode AJ, Schoenfeld JD, Chau NG, Haddad RI, Lorch JH, Wong KK, Uppaluri R, Hammerman PS.

Oral Oncol. 2017 Apr;67:61-69. doi: 10.1016/j.oraloncology.2017.02.005. Epub 2017 Feb 14.

PMID:
28351582
9.

Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial.

Uppaluri R, Winkler AE, Lin T, Law JH, Haughey BH, Nussenbaum B, Paniello RC, Rich JT, Diaz JA, Michel LP, Wildes T, Dunn GP, Zolkind P, Kallogjeri D, Piccirillo JF, Dehdashti F, Siegel BA, Chernock RD, Lewis JS Jr, Adkins DR.

Clin Cancer Res. 2017 May 1;23(9):2186-2194. doi: 10.1158/1078-0432.CCR-16-1469. Epub 2016 Nov 9.

10.

Retropharyngeal Mass.

Graboyes EM, Aranake-Chrisinger J, Uppaluri R.

JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):421-422. doi: 10.1001/jamaoto.2016.3008. No abstract available.

PMID:
27978561
11.

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.

Johanns TM, Miller CA, Dorward IG, Tsien C, Chang E, Perry A, Uppaluri R, Ferguson C, Schmidt RE, Dahiya S, Ansstas G, Mardis ER, Dunn GP.

Cancer Discov. 2016 Nov;6(11):1230-1236. Epub 2016 Sep 28.

12.

Endovascular management of internal carotid artery injuries secondary to endonasal surgery: case series and review of the literature.

Sylvester PT, Moran CJ, Derdeyn CP, Cross DT, Dacey RG, Zipfel GJ, Kim AH, Uppaluri R, Haughey BH, Tempelhoff R, Rich KM, Schneider J, Chole RA, Chicoine MR.

J Neurosurg. 2016 Nov;125(5):1256-1276. Epub 2016 Jan 15.

PMID:
26771847
13.

Pd(II) adsorption characteristics of glutaraldehyde cross-linked chitosan copolymer resin.

Nagireddi S, Katiyar V, Uppaluri R.

Int J Biol Macromol. 2017 Jan;94(Pt A):72-84. doi: 10.1016/j.ijbiomac.2016.09.088. Epub 2016 Sep 27.

PMID:
27687631
14.

Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.

Zolkind P, Dunn GP, Lin T, Griffith M, Griffith OL, Uppaluri R.

Oral Oncol. 2017 Aug;71:169-176. doi: 10.1016/j.oraloncology.2016.09.010. Epub 2016 Oct 14. Review.

PMID:
27751760
15.

nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma.

Adkins D, Ley J, Michel L, Wildes TM, Thorstad W, Gay HA, Daly M, Rich J, Paniello R, Uppaluri R, Jackson R, Trinkaus K, Nussenbaum B.

Oral Oncol. 2016 Oct;61:1-7. doi: 10.1016/j.oraloncology.2016.07.015. Epub 2016 Jul 29.

16.

Head and neck cancer immunology and immunotherapeutics: Basic concepts to clinical translational approaches.

Uppaluri R, Bell RB, Sunwoo JB.

Oral Oncol. 2016 Jul;58:49-51. doi: 10.1016/j.oraloncology.2016.05.004. Epub 2016 May 26. No abstract available.

PMID:
27238227
17.

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers.

Moore EC, Cash HA, Caruso AM, Uppaluri R, Hodge JW, Van Waes C, Allen CT.

Cancer Immunol Res. 2016 Jul;4(7):611-20. doi: 10.1158/2326-6066.CIR-15-0252. Epub 2016 Apr 13.

18.

Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis.

Vermeer DW, Coppock JD, Zeng E, Lee KM, Spanos WC, Onken MD, Uppaluri R, Lee JH, Vermeer PD.

Oncotarget. 2016 Apr 26;7(17):24194-207. doi: 10.18632/oncotarget.8254.

19.

mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer.

Cash H, Shah S, Moore E, Caruso A, Uppaluri R, Van Waes C, Allen C.

Oncotarget. 2015 Nov 3;6(34):36400-17. doi: 10.18632/oncotarget.5063.

20.

Juvenile xanthogranuloma of supra-sellar region: a rare presentation.

Stepan KO, Sharma A, Chicoine MR, Uppaluri R, Dahiya S.

Clin Neuropathol. 2015 Nov-Dec;34(6):368-70. doi: 10.5414/NP300854. No abstract available.

PMID:
26308252
21.

Genomic analysis to define molecular basis of aggressiveness in a mouse model of oral cancer.

Chalivendra V, Kanchi KL, Onken MD, Winkler AE, Mardis E, Uppaluri R.

Genom Data. 2015 Mar 1;3:61-62.

22.

Ethmoid sinus mass. Sinonasal teratocarcinosarcoma.

Yang Z, Uppaluri R, Lewis JS Jr.

JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):389-90. doi: 10.1001/jamaoto.2015.22. No abstract available.

PMID:
25695742
23.

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.

Murillo-Sauca O, Chung MK, Shin JH, Karamboulas C, Kwok S, Jung YH, Oakley R, Tysome JR, Farnebo LO, Kaplan MJ, Sirjani D, Divi V, Holsinger FC, Tomeh C, Nichols A, Le QT, Colevas AD, Kong CS, Uppaluri R, Lewis JS Jr, Ailles LE, Sunwoo JB.

Oncotarget. 2014 Aug 30;5(16):6854-66.

24.

Electrochemical conversion of CO₂ to fuels: tuning of the reaction zone using suitable functional groups in a solid polymer electrolyte.

Aeshala LM, Uppaluri R, Verma A.

Phys Chem Chem Phys. 2014 Sep 7;16(33):17588-94. doi: 10.1039/c4cp02389g.

PMID:
25025524
25.

A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease.

Onken MD, Winkler AE, Kanchi KL, Chalivendra V, Law JH, Rickert CG, Kallogjeri D, Judd NP, Dunn GP, Piccirillo JF, Lewis JS Jr, Mardis ER, Uppaluri R.

Clin Cancer Res. 2014 Jun 1;20(11):2873-84. doi: 10.1158/1078-0432.CCR-14-0205. Epub 2014 Mar 25.

26.

Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas.

Sylvester PT, Evans JA, Zipfel GJ, Chole RA, Uppaluri R, Haughey BH, Getz AE, Silverstein J, Rich KM, Kim AH, Dacey RG, Chicoine MR.

Pituitary. 2015 Feb;18(1):72-85. doi: 10.1007/s11102-014-0560-2.

27.

Efficacy of reducing agent and surfactant contacting pattern on the performance characteristics of nickel electroless plating baths coupled with and without ultrasound.

Agarwal A, Pujari M, Uppaluri R, Verma A.

Ultrason Sonochem. 2014 Jul;21(4):1382-91. doi: 10.1016/j.ultsonch.2014.01.015. Epub 2014 Jan 21.

PMID:
24480601
28.

Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1).

Lee SH, Carrero JA, Uppaluri R, White JM, Archambault JM, Lai KS, Chan SR, Sheehan KC, Unanue ER, Schreiber RD.

J Immunol. 2013 Oct 15;191(8):4223-34. doi: 10.4049/jimmunol.1300910. Epub 2013 Sep 18.

29.

Emerging insights into head and neck cancer metastasis.

Allen CT, Law JH, Dunn GP, Uppaluri R.

Head Neck. 2013 Nov;35(11):1669-78. doi: 10.1002/hed.23202. Epub 2012 Dec 22. Review.

PMID:
23280716
30.

Cancer immunoediting by the innate immune system in the absence of adaptive immunity.

O'Sullivan T, Saddawi-Konefka R, Vermi W, Koebel CM, Arthur C, White JM, Uppaluri R, Andrews DM, Ngiow SF, Teng MW, Smyth MJ, Schreiber RD, Bui JD.

J Exp Med. 2012 Sep 24;209(10):1869-82. Epub 2012 Aug 27.

31.

Feasibility and effectiveness of provider initiated HIV testing and counseling of TB suspects in Vizianagaram district, South India.

Achanta S, Kumar AM, Nagaraja SB, Jaju J, Shamrao SR, Uppaluri R, Tekumalla RR, Gupta D, Kumar A, Satyanarayana S, Dewan PK.

PLoS One. 2012;7(7):e41378. doi: 10.1371/journal.pone.0041378. Epub 2012 Jul 23.

32.

Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.

Judd NP, Allen CT, Winkler AE, Uppaluri R.

Otolaryngol Head Neck Surg. 2012 Sep;147(3):493-500. doi: 10.1177/0194599812442037. Epub 2012 Mar 19.

PMID:
22434099
33.

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.

Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, Smyth MJ, Old LJ, Mardis ER, Schreiber RD.

Nature. 2012 Feb 8;482(7385):400-4. doi: 10.1038/nature10755.

34.

The clinical implications of antitumor immunity in head and neck cancer.

Allen CT, Judd NP, Bui JD, Uppaluri R.

Laryngoscope. 2012 Jan;122(1):144-57. doi: 10.1002/lary.21913. Review.

PMID:
22183634
35.

ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.

Judd NP, Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH, Lewis JS Jr, Dunn GP, Bui JD, Sunwoo JB, Uppaluri R.

Cancer Res. 2012 Jan 1;72(1):365-74. doi: 10.1158/0008-5472.CAN-11-1831. Epub 2011 Nov 15.

36.

CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.

Winkler AE, Brotman JJ, Pittman ME, Judd NP, Lewis JS Jr, Schreiber RD, Uppaluri R.

Cancer Res. 2011 Sep 1;71(17):5707-16. doi: 10.1158/0008-5472.CAN-11-0907. Epub 2011 Jul 6.

37.

Endoscopic surgical management of vidian nerve schwannoma.

Hackman T, Rickert CG, Getz AE, Uppaluri R.

Laryngoscope. 2011 Feb;121(2):241-4. doi: 10.1002/lary.21285. Epub 2011 Jan 13.

PMID:
21271568
38.

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.

Conforti R, Ma Y, Morel Y, Paturel C, Terme M, Viaud S, Ryffel B, Ferrantini M, Uppaluri R, Schreiber R, Combadière C, Chaput N, André F, Kroemer G, Zitvogel L.

Cancer Res. 2010 Jan 15;70(2):490-500. doi: 10.1158/0008-5472.CAN-09-1890. Epub 2010 Jan 12.

39.

Novel application of the palatal island flap for endoscopic skull base reconstruction.

Hackman T, Chicoine MR, Uppaluri R.

Laryngoscope. 2009 Aug;119(8):1463-6. doi: 10.1002/lary.20298. No abstract available.

PMID:
19507226
40.

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.

Uppaluri R, Dunn GP, Lewis JS Jr.

Cancer Immun. 2008 Dec 4;8:16. Review.

41.

Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.

Uppaluri R, Sheehan KC, Wang L, Bui JD, Brotman JJ, Lu B, Gerard C, Hancock WW, Schreiber RD.

Transplantation. 2008 Jul 15;86(1):137-47. doi: 10.1097/TP.0b013e31817b8e4b.

42.

Oxidative desulfurization: kinetic modelling.

Dhir S, Uppaluri R, Purkait MK.

J Hazard Mater. 2009 Jan 30;161(2-3):1360-8. doi: 10.1016/j.jhazmat.2008.04.099. Epub 2008 May 2.

PMID:
18541367
43.

Pathology quiz case 2. Atypical meningioma with clear cell features (World Health Organization [WHO] grade II).

Brenner MJ, Perrin RJ, Uppaluri R, Zipfel GJ, Lewis JS Jr.

Arch Otolaryngol Head Neck Surg. 2008 Apr;134(4):447-9. doi: 10.1001/archotol.134.4.447. No abstract available.

PMID:
18427017
44.

Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia.

Dunn GP, Lewis JS Jr, Sunwoo JB, Uppaluri R.

Head Neck. 2008 Feb;30(2):267-72.

PMID:
17657794
45.

Mycotic pseudoaneurysm of the internal maxillary artery: case report and review of the literature.

Dunn GP, Uppaluri R, Hessler JL, Layland MK, Derdeyn CP, Sunwoo JB.

Arch Otolaryngol Head Neck Surg. 2007 Apr;133(4):402-6. Review.

PMID:
17438257
46.
47.

Association of reflux with otitis media in children.

Lieu JE, Muthappan PG, Uppaluri R.

Otolaryngol Head Neck Surg. 2005 Sep;133(3):357-61.

PMID:
16143181
48.

Interferon-gamma and cancer immunoediting.

Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD.

Immunol Res. 2005;32(1-3):231-45. Review.

PMID:
16106075
49.

A critical function for type I interferons in cancer immunoediting.

Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD.

Nat Immunol. 2005 Jul;6(7):722-9. Epub 2005 Jun 12. Erratum in: Nat Immunol. 2005 Aug;6(8):852.

PMID:
15951814
50.

Management of pediatric radiation dose using GE's Revolution digital radiography systems.

Jabri KN, Uppaluri R, Xue P.

Pediatr Radiol. 2004 Oct;34 Suppl 3:S215-20; discussion S234-41.

PMID:
15558264

Supplemental Content

Loading ...
Support Center